Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04748601 · ClinicalTrials.gov registry record · Phase 4
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
A Phase 4 study of Migraine Disorders, sponsored by Upsher-Smith Laboratories.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 132
- Enrollment target
- 15
- Study locations
NCT04748601 is a Phase 4 study of Migraine Disorders that is actively recruiting participants, run by Upsher-Smith Laboratories. The registered enrollment target is 132 participants, below the 309-participant average among 21 other Migraine Disorders trials with a reported enrollment target (57% lower). The trial reports 15 study locations across 12 states.
The verdict
NCT04748601, a Phase 4 study of Migraine Disorders, is actively recruiting participants, sponsored by Upsher-Smith Laboratories.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 132 participants
- Enrollment target
- 15
- Study locations
Study Summary
A Phase 4 study to evaluate Qudexy XR for the prevention of migraine in children 6 to 11 years of age.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Qudexy XR
Study Locations (15)
Florida
- Upsher-Smith Clinical Trial Site #12 - Loxahatchee Groves
- Upsher-Smith Clinical Trial Site #8 - Orlando
- Upsher-Smith Clinical Trial Site #14 - Tampa
Oregon
- Upsher-Smith Clinical Trial Site #6 - Portland
- Upsher-Smith Clinical Trials Site #7 - Springfield
Alabama
- Upsher-Smith Clinical Trial Site #5 - Birmingham
California
- Upsher-Smith Clinical Trial Site #15 - La Jolla
Colorado
- Upsher-Smith Clinical Trials Site #3 - Aurora
Connecticut
- Upsher-Smith Clinical Trial Site #1 - Stamford
Michigan
- Upsher-Smith Clinical Trial Site #2 - Ann Arbor
Mississippi
- Upsher-Smith Clinical Trial Site #11 - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2021-02-19 |
| Est. Completion | 2026-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04748601
The ClinicalTrials.gov registry entry for NCT04748601 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 309-participant average among 21 other Migraine Disorders trials with a reported enrollment target (57% lower). The listed sponsor is Upsher-Smith Laboratories, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Migraine Disorders appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04748601 reports 15 study locations spanning 12 distinct geographic areas - top geographies include Florida, Oregon, Alabama.
Frequently Asked Questions
What is clinical trial NCT04748601 about?
NCT04748601 is a clinical study titled "Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old". A Phase 4 study to evaluate Qudexy XR for the prevention of migraine in children 6 to 11 years of age.
What is the current status of trial NCT04748601?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 132 participants. The study started on 2021-02-19. Estimated completion is 2026-09.
What conditions does trial NCT04748601 study?
This clinical trial studies the following conditions: Migraine Disorders.
What interventions are being tested in trial NCT04748601?
The interventions under investigation include: Placebo (DRUG), Qudexy XR (DRUG).
Who is sponsoring clinical trial NCT04748601?
This trial is sponsored by Upsher-Smith Laboratories, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04748601 being conducted?
This trial has 15 study locations across Alabama, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period
COMPLETED · Phase 4
-
Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults
COMPLETED · Phase 4
-
Migraine Manager (R01)
RECRUITING · Phase 2
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
-
Mind Body Balance for Pediatric Migraine
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.